Related Experiment Video
Updated: May 19, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Frequency and microbiology of peritonitis and exit-site infection among obese peritoneal dialysis patients
Sharon J Nessim1, Paul Komenda, Claudio Rigatto
1Division of Nephrology, Jewish General Hospital, and McGill University, Montreal, Quebec, Canada. sharon.nessim@mcgill.ca
Background:
Data on obesity as a risk factor for peritonitis and catheter infections among peritoneal dialysis (PD) patients are limited. Furthermore, little is known about the microbiology of PD-related infections among patients with a high body mass index (BMI).
Methods:
Using a cohort that included all adult patients residing in the province of Manitoba who received PD during the period 1997 - 2007, we studied the relationship between BMI and PD-related infections. After categorizing patients into quartiles of BMI, a multivariate Cox regression model was used to determine the independent relationship between BMI and peritonitis or exit-site infection (ESI). We also studied whether increasing BMI was associated with a propensity to infections with particular organisms.
Results:
Among 990 PD patients, 938 (95%) had accurate BMI data available. Those 938 patients experienced 1338 peritonitis episodes and 1194 exit-site infections. In unadjusted analyses, patients in the highest BMI quartile (median: 33.5; interquartile range: 31.9 - 36.4) had an increased risk of peritonitis overall, and also an increased risk of peritonitis with gram-positive organisms and coagulase-negative Staphylococcus (CNS). After multivariate adjustment for age, sex, diabetes, cause of renal disease, Aboriginal race, PD modality, and S. aureus nasal carriage, the relationship between overall peritonitis risk and BMI disappeared, but the increased risk of CNS peritonitis among patients in the highest BMI quartile persisted (hazard ratio: 1.80; 95% confidence interval: 1.06 to 3.06; p = 0.03). There was no increased risk of ESI among patients in the highest BMI quartile on univariate analysis or after multivariate adjustment.
Conclusions:
Among Canadian PD patients, obesity was not associated with an increased risk of peritonitis overall, but may be associated with a higher risk of CNS peritonitis.
Insights
Obesity in peritoneal dialysis patients did not increase overall peritonitis risk. However, higher body mass index (BMI) was linked to an increased risk of coagulase-negative Staphylococcus (CNS) peritonitis in this Canadian cohort.
Area of Science:
- Nephrology
- Infectious Diseases
- Epidemiology
Background:
- Limited data exists on obesity as a risk factor for peritonitis and catheter infections in peritoneal dialysis (PD) patients.
- The microbiology of PD-related infections in high body mass index (BMI) patients is not well understood.
Purpose of the Study:
- To investigate the relationship between BMI and the risk of PD-related infections, specifically peritonitis and exit-site infection (ESI).
- To explore if increasing BMI is associated with specific causative organisms in PD infections.
Main Methods:
- A cohort study of adult PD patients in Manitoba (1997-2007) was conducted.
- Patients were categorized into BMI quartiles.
- Multivariate Cox regression analysis was used to assess the independent relationship between BMI and peritonitis or ESI risk, controlling for confounding factors.
Main Results:
- In the highest BMI quartile, unadjusted analysis showed increased risk for overall peritonitis and gram-positive/coagulase-negative Staphylococcus (CNS) peritonitis.
- After multivariate adjustment, the overall peritonitis risk associated with BMI disappeared.
- However, the increased risk of CNS peritonitis persisted in the highest BMI quartile (HR: 1.80; 95% CI: 1.06-3.06).
- No increased risk of ESI was found in the highest BMI quartile.
Conclusions:
- Obesity is not associated with an increased risk of overall peritonitis in Canadian PD patients.
- A higher BMI may be associated with an increased risk of coagulase-negative Staphylococcus (CNS) peritonitis.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Peritoneal Dialysis I: Introduction and Procedure
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

